OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCĪ“/p53
Crossref DOI link: https://doi.org/10.3389/fphar.2016.00463
Published Online: 2016-11-30
Update policy: https://doi.org/10.3389/crossmark-policy
Omar, Hany A.
Tolba, Mai F.
Hung, Jui-Hsiang
Al-Tel, Taleb H.
Funding for this research was provided by:
Al Jalila Foundation (AJF201424)
